T4交感神经链切断术治疗手汗症33例

目的 探讨T4交感神经链切断术治疗手汗症的疗效.方法 回顾性分析该院2008年11月～2010年8月,对33例手汗症患者行胸腔镜下T4交感神经链切断术.结果 全部手术顺利,33例术后手掌多汗症状均消失,术前伴足底多汗24例、腋汗13例,术后症状消失或明显减轻分别为17例(70.8％)和11例(84.6％).术后6例(18.2％)出现不同部位代偿性出汗,其中轻度为5例(15.2％),中度为1例(3.0％),无1例重度代偿性出汗.结论 T4交感神经切断术治疗手汗症操作简单,副作用小,是安全、有效的治疗方法.     

胸腔镜下T3～4交感神经干切断术治疗原发性手足多汗症的优势分析

目的:比较胸腔镜下T3～4与T3两种不同水平交感神经干切断术对手、足出汗的缓解情况和发生代偿性多汗的异同,分析前者的临床应用优势.方法:回顾性对我科2007年7月至2008年12月开展的胸腔镜下胸上段交感神经干切断术160例临床资料进行对照分析,接不同手术方式分为T3-4组(行T3～4水平胸交感神经干切断术,共93例)和T3组(行T3水平交感神经干切断术,共67例).分别对两组病例进行随访,比较两组之间手掌、足底出汗的疗效以及代偿性多汗的异同.结果:两组手多汗有效率均为100%,无复发病例;足底多汗有效率分别为89.4%、73.1%,差异有统计学意义(χ2=6.717,P＜0.05);轻-中度代偿性多汗发生率分别为16.1%和15.4%,差异无统计学意g(χ2=0.222,P＞0.05),无重度代偿性多汗.结论:T3～4交感神经干切断术能有效治疗手出汗的同时,明显提高足底多汗的缓解率,并不增加代偿性多汗的发生率,是一种较为理想的手术方式.     

围术期心理干预对减轻胸交感神经切断术后代偿性多汗的意义

目的探讨围术期心理干预对减轻胸交感神经切断术后严重代偿性多汗的效果。方法分析2007年7月至2012年8月253例成功手术的因手多汗症行胸交感神经切断术患者,比较切断T3或T4不同平面胸交感神经及围术期心理干预后,代偿性多汗严重程度的发生率。结果 143例未进行特殊心理干预的手术患者,T3手术平面患者术后重度代偿性多汗发生率为15.15%(10/66),T4手术平面为9.1%(7/77),差异有统计学意义(P0.01)。110例经心理干预的患者手术后均未出现重度代偿性多汗,未进行心理干预的143例手术患者术后总的重度代偿性多汗发病率为11.89%(17/143),两组比较差异有统计学意义(P0.01)。结论围术期的心理干预可以从心理方面避免及克服患者对出汗的焦虑,对减轻术后严重代偿性多汗有显著效果。     

不同节段交感神经干切断术治疗手汗症术后疼痛疗效比较

目的：比较针形胸腔镜下T2-4和T3-4不同节段交感神经干切断术治疗手汗症术后疼痛的疗效。方法：总结分析2007年12月—2009年6月期间完成的166例手足多汗症患者术后当天疼痛情况、止痛药应用情况及术后1个月疼痛情况。依据切断交感神经节段的不同分为两组。A组：行双侧T2-4交感神经干切断术,共66例;B组：行双侧T3-4交感神经干切断术,共100例。结果：两组手术均顺利完成,A组和B组手术当天疼痛的发生率分别为48.5%（32/66）、17.0%（17/100）,A组中重度疼痛的发生率及使用止痛药物（曲马多）的剂量明显高于B组。A组和B组术后1个月疼痛的发生率分别为16.7%（11/66）、3.0%（3/100）,A组明显高于B组（P=0.002）,两组术后疼痛程度差异无统计学意义（P=0.51）。结论：T3-4交感神经干切断术治疗手汗症术后疼痛发生率较低,疼痛程度较轻,使用止痛药物剂量较少。     

一孔法胸腔镜下交感神经链切断术治疗手汗症30例临床研究

目的探讨一孔法电视胸腔镜下T3或T4交感神经链及其侧支切断术治疗手汗症的可行性。方法在全麻双腔气管插管下施行T3或T4交感神经链及其侧支切断术治疗手汗症30例。结果30例手术均获成功,术后患者手掌多汗症状消失,有效率为100％,术后掌温升高（2．5±0．8）℃。30例随访1．5-12个月,平均8月,无一例复发及严重代偿性多汗．轻度代偿性多汗1例,占3．3％0／30）。结论一孔法电视胸腔镜下]r3或T4交感神经链及其侧支切断术治疗手汗症疗效确切,创伤小,疼痛较轻,且术后代偿性多汗发生率低,程度轻微,是一种安全、有效的手术方式。     

胸腔镜下三种手术方式对手汗症疗效的影响

目的评价电视胸腔镜下三种手术方式治疗手汗症的疗效及并发症。方法回顾性分析2000年2月至2006年10月80例手汗症的外科治疗临床资料,Ⅰ组胸交感神经干T2~T4段切除术21例,Ⅱ组胸交感神经干T2、T3、T4切断术25例,Ⅲ组胸交感神经T3、T4切断 两侧3 cm范围的分支切断术34例,比较3组手术前后的掌温变化、手术效果和躯干代偿性多汗的发生率。结果3组病人全部在胸腔镜下完成,3组病人术后掌温比术前上升1~4℃(掌温差P<0.01),手术疗效相同(有效率均为100%),术后住院时间1~4 d,平均2.3 d;Ⅰ、Ⅱ和Ⅲ组术后躯干代偿性多汗发生率分别为33.3%(7/21)、32.0%(8/25)和5.9%(2/34),Ⅲ组低于Ⅰ、Ⅱ组(P<0.05),Ⅰ与Ⅱ组统计学上无差异(P>0.05),3组均无发生严重手术并发症,无住院死亡,术后未见复发。结论三种手术方式都能有效治疗手汗症,安全可靠,但胸交感神经T3、T4切断 两侧3 cm范围的分支切断术可有效降低躯干代偿性多汗的发生率,是手汗症较为理想的手术方式。     

胸3～4与胸3～5交感神经干切除术治疗手足多汗症

目的:比较胸3～4 (T3～4)与胸3～5(T3～5)交感神经干切除术治疗手足多汗症的安全性及有效性.方法:239例手足多汗症患者分别行T3～4切除术(A组,155例)与T3～4切除术加T5部分电灼切断(B组,84例),比较两组疗效、并发症及患者满意度.结果:全部患者无严重并发症及手术死亡,术后手多汗均得到缓解,随访期限内无复发.137例(58％)患者术后足汗消失或得到缓解,其中B组55例(67％),A组82例(53％),两组比较差异具统计学意义(P＜0.05).两组患者术后代偿性多汗发生率分别为40％(A组)和36％(B组),组间比较差异无统计学意义.结论:T3～4切除术与T3～4切除术加T5部分电灼切断对手多汗均具理想疗效,后者能提高足多汗缓解率而不增加并发症,适用于合并足多汗患者.     

胸腔镜下交感神经链切断术治疗原发性手汗症疗效观察

目的观察比较胸腔镜下交感神经链切断术于T2及T3水平治疗原发性手汗症的治疗效果。方法应用电视胸腔镜交感神经链切断术治疗手汗症患者42例,其中25例行T2~4节段交感神经干切断术,17例行T3~4节段交感神经干切断术。术后1、6、12及24个月门诊及电话随访,观察患者手汗症复发情况及术后代偿性多汗的情况。结果全组术后手掌多汗症状立即消失,双手干燥温暖;术后3~6天出院,平均住院时间（4.1±0.8）天;无手术死亡和切口感染,术后随访期间无Horner s综合征出现,无复发病例;两种手术方式的代偿性多汗的发生率在各个观察期无明显差异（P〉0.05）;代偿性多汗严重程度在术后1个月随访时两组差异不明显,6个月及12个月时T2~4节段交感神经干切断术的代偿性多汗明显较T3~4节段交感神经干切断术严重（P〈0.05）。结论胸腔镜下交感神经干切断术治疗手汗症,术后无复发,T2切除节段及T3节段术后代偿性多汗情况无差异,但T2节段代偿性多汗较T3节段明显严重。     

单孔法胸腔镜下T3/T4胸交感神经链切断术治疗原发性手汗症27例的效果观察

目的探讨单孔法胸腔镜下T_3/T_4胸交感神经链切断术治疗原发性手汗症的效果。方法选取单孔法胸腔镜下行T_3或T_4胸交感神经链切断术治疗原发性手汗症27例。分别记录患者交感神经链切断术前、术后掌温变化情况及治疗情况。结果 27例患者手术均获得成功,无1例中转开胸。术后随访1～12月,平均6月,无复发病例。手术时间(50. 0±9. 1) min,术中出血量(5. 0±2. 5) m L,术后掌温升高(1. 3±0. 2)℃,住院时间(5. 7±2. 3) d。平均住院费用9 800元。1例患者术后出现气胸,3例患者术后5～6 d出现颜面部、前胸部代偿性多汗,7～14 d后均能缓解。无血胸、心脏骤停、Horner综合征等并发症发生。手术治疗有效率100. 0%,腋窝和足底多汗症状得到改善。结论单孔法胸腔镜下T_3/T_4胸交感神经链切断术治疗原发性手汗症安全、有效。     

针形胸腔镜下不同节段胸交感干切除对足多汗的影响

目的:探讨增加胸5节段交感干切断能否提高胸3-4交感切除术对足多汗的缓解率。方法:回顾分析比较本单位2008年7月至2010年7月间,行针形胸腔镜下胸3-4交感干切除术(T3-4)和胸3-4交感干切除+胸5切断术(T3-4/5)的手足多汗症患者临床及随访资料。结果:共计239例患者符合条件,A组(T3-4)155例,B组(T3-4/5)84例,B组失访2例。全组患者无严重并发症及手术死亡,术后手多汗均得到缓解。137例(57.8%)患者术后足汗消失或得到缓解,其中B组55例(67.1%),A组82例(52.9%),两组间差异有统计学意义(P=0.02)。两组患者术后代偿性多汗发生率分别为40.0%(A组)和36.6%(B组),组间差异无显著性。结论:增加T5切断可以提高(T3-4)交感切除术对足多汗的缓解率而不增加并发症率,(T3-4/5)交感切除术尤其适合手足多汗症患者。     

Sympathotomy instead of sympathectomy for palmar hyperhidrosis: minimizing postoperative compensatory hyperhidrosis

OBJECTIVE: To determine whether anatomical modification of sympathectomy diminishes severe postoperative compensatory hyperhidrosis. PATIENTS AND METHODS: From January 1, 2000, to June 1, 2001, we prospectively studied 10 consecutive patients with primary palmar hyperhidrosis, aged 14 to 42 years. Medical therapy had failed in all patients. A preoperative and postoperative evaluation and thermoregulatory sweat testing were conducted in all patients. All patients underwent sympathotomy (bilateral simple disconnection) of the second thoracic ganglion input into the brachial plexus, and no sympathetic ganglia were violated. RESULTS: In the 10 patients, all 20 upper extremities improved postoperatively: 11 (55%) had near-complete cessation of palmar sweating, 8 (40%) had marked reduction in sweating, and 1 (5%) had delayed onset but full sweating at the end of the thermoregulatory sweat test. No intraoperative complications of hemopneumothorax or Horner syndrome occurred. Importantly, there were no moderate or severe postoperative hyperhidrosis complications. CONCLUSION: Sympathotomy to disconnect T2 ganglion input into the brachial plexus produces excellent results in the treatment of primary palmar hyperhidrosis and may lower the severity of postoperative compensatory hyperhidrosis complications. Long-term durability of the procedure requires further follow-up.     

胸腔镜下交感神经链切除术治疗双手多汗症(12例报告)

目的评价内镜下胸交感神经链切除术治疗多汗症的临床效果。方法回顾性分析内镜下胸交感神经链切除术治疗12例多汗症的结果。结果12例术后多汗症均治愈，2例术后2d发生背部、双股部不同程度代偿性出汗，3～6个月后缓解，术后获得随访的10例未见复发。结论胸腔镜下交感神经链切除手术安全、疗效确切、创伤小，缩短住院时间。     

Thoracoscopic sympathectomy for palmaris hyperhidrosis

INTRODUCTION: Palmaris hyperhidrosis is a disorder mediated by the sympathetic nervous system. It causes excessive sweating. This study evaluated the safety, efficacy, and outcome after thoracoscopic sympathectomy in patients with palmaris hyperhidrosis. METHODS: We reviewed the medical records of 18 patients (10 male) who underwent bilateral thoracoscopic sympathectomy between July 1998 and June 2001. RESULTS: The patients' mean age was 34 years. No conversions to thoracotomy occurred. Three 2- to 5 mm trocars were used.The thoracic sympathetic chain was resected from ganglia T2-T4, except in one patient with axillary hyperhidrosis requiring resection to T5. The mean operating time was 112 minutes, the mean blood loss was 50 ml, and the mean postoperative hospital stay was 1.2 days. Two patients had a unilateral pneumothorax requiring tube thoracostomy; one patient developed a chest wall hematoma at a trocar site that resolved without treatment, and one patient developed a transient unilateral Horner's syndrome. There have been no hospital readmissions. After a mean follow-up period of 14 months, 11 patients (56%) reported compensatory sweating. Sixteen patients (89%) were satisfied with their outcomes. One patient was dissatisfied because of excessive compensatory sweating, and another continues to have mild unilateral sweating on one hand and compensatory sweating of the face. CONCLUSION: Thoracoscopic sympathectomy is a safe and effective alternative treatment for palmaris hyperhidrosis. Compensatory sweating occurs in more than 50% of patients but is tolerable in most. The majority of patients are satisfied with their short-term outcomes.     

Craniofacial hyperhidrosis treated with video endoscopic sympathectomy

Craniofacial hyperhidrosis as well as palmar hyperhidrosis is an abnormal state of local excessive sweating of unclear etiology. The hyperhidrosis may be isolated in the craniofacial region or associated with palmar hyperhidrosis. The patient's face is so wet with sweat that their daily activities are often seriously disturbed. To the best of our knowledge, there has been no satisfactory medical therapy, nor any effective surgical treatment reported in the literature. In 1991, we started to treat a patient with such distress using endoscopic ablation of the sympathetic T2 segment, because we mastered the technique after treating a large series of palmar hyperhidrosis patients. Furthermore, we were impressed by concomitant reduction of craniofacial sweating after T2-3 sympathectomy resulting from the relatively different domination of sympathetic supply between the eye and face. It appears possible to relieve excessive sweating of the head and face, without producing ptosis or miosis by ablation of the T2 segment. During the past 2 years, 7 patients with severe craniofacial hyperhidrosis have been successfully treated with the method and all obtained a satisfactory result. No complete Horner's syndrome has been produced except in one patient, who showed a mild and transient left eye ptosis, in whom coagulation of the sympathetic trunk higher than the T2 segment was performed. Intraoperative monitoring of forehead skin perfusion and observation of the change of pupillary size is emphasized during the lesion making. The longest postoperative follow-up was 2 years, with a mean follow-up of 12.4 months.(ABSTRACT TRUNCATED AT 250 WORDS)     

两种不同入路单孔胸腔镜T3交感神经链切断术的应用对比研究

目的对比两种不同入路(经剑突下入路与经两侧腋下入路)单孔胸腔镜双侧T3交感神经链切断术治疗原发性手汗症的可行性及安全性。方法从2011年10月-2015年9月,该科共完成单孔胸腔镜双侧T3交感神经链切断术治疗手汗症47例,其中经剑突下单孔胸腔镜行双侧T3交感神经链切断术11例(A组),经双侧腋下单孔胸腔镜行T3交感神经链切断术36例(B组),通过观察术后疼痛、术后并发症、症状好转程度、远期有无复发及代偿性多汗等指标,对比两种不同入路单孔胸腔镜手术的疗效及安全性。结果两组患者均顺利完成手术,A组平均手术时间为(74.00±12.00)min,术后平均住院时间为(2.00±0.70)d,术后1周使用镇痛药物氨酚双氢可待因平均剂量(26.30±9.20)mg,B组平均手术时间为(56.00±16.00)min,术后平均住院时间为(2.30±1.00)d,术后1周使用镇痛药物氨酚双氢可待因平均剂量(48.30±12.00)mg。近期均无血胸、气胸、Hornor综合征等并发症,随访两组均无复发,两组患者对比围手术期数据,经剑突下入路手术平均时间较经双侧腋下入路手术长,术后各项并发症及治疗效果差异无统计学意义,但术后疼痛程度明显减轻。结论与传统的经双侧腋下切口单孔胸腔镜T3胸交感神经链切断术相比,经剑突下单孔胸腔镜治疗手汗症具有更微创的优势,减轻了术后出现的肋间神经疼痛症状,疗效及安全性确切,值得进一步推广。